Susan E Critchlow

6PUBLICATIONS
145CO-AUTHORS
Molecular targetsPharmacogenomicsCarbon capture engineering (excl. sequestration)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 08, 2024
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations.

Azadeh C Bashi, Elizabeth A Coker, Krishna C Bulusu

|Nov 15, 2023
Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1.

Anna D Staniszewska, Domenic Pilger, Sonja J Gill

|Sep 19, 2023
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance.

Mandy Lawson, Natalie Cureton, Susana Ros

|Nov 02, 2022
A functional analysis of 180 cancer cell lines reveals conserved intrinsic metabolic programs.

Sarah Cherkaoui, Stephan Durot, Jenna Bradley

|Aug 05, 2022
Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper.

Giuditta Illuzzi, Anna D Staniszewska, Sonja J Gill

|Aug 03, 2022
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance.

Violeta Serra, Anderson T Wang, Marta Castroviejo-Bermejo

Pageof 1

Frequent Collaborators

4 joint publications

Mark J O'Connor

3 joint publications

Stephen Fawell

3 joint publications

Gareth Maglennon

2 joint publications

Violeta Serra